Shu-Chun Chang is Assistant Professor of the Ph.D. Program for Translational Medicine, Taipei Medical University. Dr. Chang worked on cancer research as her PhD study in Imperial College London (2007–2011). She continued to work in the field of Immunology/inflammation as a Post-Doc at National University of Singapore (NUS, 2011–2015). Her findings identified E3 ligase as a key switch between life and death (by apoptosis) and immune response OR immune-overactivation and tumorigenesis. Her current interests are in chronic inflammation-associated tumors (e.g., breast cancer and lung cancer), and this has a profound impact in identifying new molecular anti-cancer therapies.